These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 1178820)

  • 1. The aetiology of senile osteoporosis: secondary hyperparathyroidism due to renal failure.
    Berlyne GM; Ben-Ari J; Kushelevsky A; Idelman A; Galinsky D; Hirsch M; Shainkin R; Yagil R; Zlotnik M
    Q J Med; 1975 Jul; 44(175):505-21. PubMed ID: 1178820
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early radiographic manifestations of secondary hyperparathyroidism associated with chronic renal disease.
    Jensen PS; Kliger AS
    Radiology; 1977 Dec; 125(3):645-52. PubMed ID: 928688
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Results of bone scintigraphy, densitometry and radiography in secondary hyperparathyroidism in patients with chronic renal failure].
    Kosowicz J; Bolko P; Swiderski A
    Pol Arch Med Wewn; 2003 Feb; 109(2):125-35. PubMed ID: 12879775
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Secondary osteoporosis in patients with steroid-dependent asthma].
    Pluskiewicz W; Rogala E
    Przegl Lek; 1997; 54(1):21-4. PubMed ID: 9190629
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radioimmunoassay of carboxyl and amino terminal fragments of parathyroid hormone for the evaluation of secondary hyperparathyroidism in chronic renal failure.
    Zanella MT; Silva MC; Peres RB; Ferreira SR; Draibe SA; Vieira JG
    Braz J Med Biol Res; 1990; 23(3-4):235-43. PubMed ID: 2094538
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduced binding of [3H]1,25-dihydroxyvitamin D3 in the parathyroid glands of patients with renal failure.
    Korkor AB
    N Engl J Med; 1987 Jun; 316(25):1573-7. PubMed ID: 3035373
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Radioimmunologic determination of circulating parathyroid hormone in patients with primary and secondary hyperparathyroidism].
    Lo Giudice C; Cascone C; Manente P; Gasparoni P; De Luca M; Rota G; Conte N
    Minerva Med; 1982 Dec; 73(48):3425-8. PubMed ID: 7177469
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Possible role of inorganic sulphate in the pathogenesis of hyperparathyroidism in chronic renal failure.
    Michalk D; Tschöpe W; Böhles HJ; Mehls O
    Proc Eur Dial Transplant Assoc; 1981; 18():561-6. PubMed ID: 7329984
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk Factors of Parathyroid Dysfunction in Elderly Patients with Chronic Kidney Disease Undergoing Hemodialysis.
    Li W; Zhang S
    Adv Clin Exp Med; 2015; 24(6):1007-12. PubMed ID: 26771973
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Secondary hyperparathyroidism in chronic renal failure. Role of subtotal parathyroidectomy].
    Tarquini A; Nicolosi A; Massidda B; Bolasco P; Altieri P; Massidda C
    Minerva Chir; 1991 May; 46(10):501-6. PubMed ID: 1922866
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cinacalcet for secondary hyperparathyroidism in patients receiving hemodialysis.
    Block GA; Martin KJ; de Francisco AL; Turner SA; Avram MM; Suranyi MG; Hercz G; Cunningham J; Abu-Alfa AK; Messa P; Coyne DW; Locatelli F; Cohen RM; Evenepoel P; Moe SM; Fournier A; Braun J; McCary LC; Zani VJ; Olson KA; Drüeke TB; Goodman WG
    N Engl J Med; 2004 Apr; 350(15):1516-25. PubMed ID: 15071126
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Early treatment of secondary hyperparathyroidism in moderate renal insufficiency: low-phosphorus diet versus calcium carbonate].
    Aresté N; Amor J; Cambil T; Salgueira M; Sánchez-Palencia R; Páez C; Gómez O; Palma A
    Nefrologia; 2003; 23 Suppl 2():64-8. PubMed ID: 12778857
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Secondary hyperparathyroidism in chronic renal failure.
    Malmaeus J
    Scand J Urol Nephrol Suppl; 1983; 70():1-63. PubMed ID: 6351238
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The calcimimetic AMG 073 reduces parathyroid hormone and calcium x phosphorus in secondary hyperparathyroidism.
    Lindberg JS; Moe SM; Goodman WG; Coburn JW; Sprague SM; Liu W; Blaisdell PW; Brenner RM; Turner SA; Martin KJ
    Kidney Int; 2003 Jan; 63(1):248-54. PubMed ID: 12472790
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effects of intermittent treatment with sevelamer hydrochloride on parathyroid hyperplasia and vascular calcification in rats with chronic kidney disease].
    Nagano N; Miyata S; Abe M; Wakita S; Kobayashi N; Wada M
    Clin Calcium; 2005 Sep; 15 Suppl 1():35-9; discussion 39-40. PubMed ID: 16272627
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is anemia of chronic renal failure related to secondary hyperparathyroidism?
    Podjarny E; Rathaus M; Korzets Z; Blum M; Zevin D; Bernheim J
    Arch Intern Med; 1981 Mar; 141(4):453-5. PubMed ID: 7212887
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Parathyroidectomy in chronic renal failure.
    Sivula A; Kuhlbäck B; Kock B; Kahri A; Wallenius M; Edgren J
    Acta Chir Scand; 1979; 145(1):19-25. PubMed ID: 433513
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alphacalcidol oral pulses are effective in secondary hyperparathyroidism prior to dialysis.
    Koskimies O; Ala-Houhala M
    Clin Nephrol; 1996 Jul; 46(1):70-1. PubMed ID: 8832157
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Surgical treatment of secondary hyperparathyroidism in patients with chronic renal failure].
    Hamouda M; Ben Dhia N; Aloui S; Gorsane I; Skhiri H; Frih A; Koobaa J; Driss N; Bouzouita K; Elmay M
    Nephrol Ther; 2011 Apr; 7(2):105-10. PubMed ID: 21112268
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of the molecular forms of immunoreactive parathyroid hormone in primary hyperparathyroidism and in hyperparathyroidism due to renal failure.
    Gautvik KM; Gautvik VT; Halvorsen JF
    Scand J Clin Lab Invest; 1983 Nov; 43(7):553-64. PubMed ID: 6658372
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.